News
- InvestING In Pharmaceutics And Manufacturing Capabilities 4/5/2024
-
Lifecore Biomedical Concludes Strategic Evaluation Process, Announces Management Succession And Board Changes
3/22/2024
Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that its Board of Directors unanimously approved the conclusion of its review of strategic alternatives that was initiated in March 2023, and, concurrently therewith, announced several strategic updates related to its operations on a stand-alone basis.
-
Kindeva Drug Delivery Welcomes Jennifer Riter, New Vice President of Analytical Services
3/18/2024
Kindeva Drug Delivery (Kindeva), a global leader in drug-device combination products, today welcomes Jennifer Riter as Vice President of Analytical Services to head up the recently announced analytical services global business unit. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240318401921/en/ Jennifer Riter joins Kindeva Drug Delivery as Vice President of Analytical Services to lead new analytical services business unit. (Photo: Business Wire) Riter comes to Kindeva from West Pharmaceutical where she
-
Aptar Pharma Continues Global Expansion with North America Capacity Extension at Congers, New York Site
3/14/2024
Aptar Pharma, part of AptarGroup, Inc., a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced the next phase of its global capacity expansion plan in North America, at its Aptar Congers, New York site. This investment will help Aptar meet the growing prescription and consumer healthcare customer demand for proprietary drug delivery systems in North America. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240314837664/en/ Photo: Aptar
-
SMC Ltd. Announces Expansion Of Sterile Fill Finish Capabilities, Unveiling State-Of-The-Art Facility In North Carolina
3/13/2024
SMC Ltd., the worldwide contract manufacturer of single use and disposable medical devices, has today announced the acquisition of an end-to-end fill/finish facility in Charlotte, North Carolina. The facility enables SMC to offer a wider portfolio of services to its pharma clients including lab-to-market development, analytical services, device manufacture, fill/finish, final assembly, and secondary packaging.
-
SGD Pharma Successfully Trials Hydrogen Burners At Its Saint-Quentin-Lamotte (SQLM) Plant To Accelerate Its Ambitious Decarbonization Roadmap
3/12/2024
At the end of January, SGD Pharma, a global leader in glass primary packaging for the pharmaceutical industry, started a two-week trial using 100% hydrogen burners for industrial-scale glass production. The trial, conducted at SGD Pharma’s state-of-the-art Saint-Quentin-Lamotte (SQLM) manufacturing plant in France, was a resounding success and will inform SGD Pharma’s decarbonization roadmap which aims to reduce CO2 emissions from 2020 by 35% in 2030 and by 65% in 2040.
-
Bringing Engineering, Clinical Study Expertise To A New Collaboration
3/8/2024
Battelle, the world’s largest independent, non-profit R&D company, and Spark Biomedical, Inc., a Dallas-based pioneer in wearable neurostimulation technologies are collaborating on the development of a non-invasive device to tackle the harmful effects of Acute Stress Reactions (ASR).
-
Aprecia And Battelle Are Impacting The Pharmaceutical Industry Through 3D Printing Innovation
3/8/2024
Aprecia, a precision drug delivery company, has partnered with the research and development experts at Battelle to develop groundbreaking 3D printing platforms with the potential to transform the way medicines are developed, manufactured, distributed, and administered.
-
Elizabeth Hickman To Succeed Tim Scott As AustinPx CEO
3/5/2024
AustinPx, developers of the next generation amorphous dispersion platform, KinetiSol™ Technology, and a contract development and manufacturing organization (CDMO), today announced that Elizabeth Hickman, chief business officer, will succeed Tim Scott in January 2025 as president and CEO of AustinPx. Scott has led the company’s new direction as a CDMO since 2022, successfully positioning the company’s leadership as an oral drug delivery dosage form development CDMO. Scott will stay on as executive chair following the transition and Hickman will be named to the Board of Directors.
-
Allegheny Performance PlasticsĀ® Launches Into Healthcare Sector
3/5/2024
To meet the growing needs of the healthcare industry, Allegheny Performance Plastics is proud to announce the addition of clean and white room environments, including a dedicated automated work cell to be completed later this year.